Clinical trial
Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia
NCT03035344 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia
- Lead sponsor
- Aristotle University Of Thessaloniki
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2015
- Completion date
- November 30, 2018
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, pediatric, metabolism disorder